Publications by authors named "Joshua D Rosenblat"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

146

Total Likes

54

Extended Reach

63,166

Social Features

19
T
The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis.
Caroline Park, Amna Majeed, Hartej Gill, Jocelyn Tamura, Roger C Ho, Rodrigo B Mansur, Flora Nasri, Yena Lee, Joshua D Rosenblat, Elizabeth Wong

Psychiatry Res· December 2020

Videos about Article: user

1 18 4 27

View All Article and Social Media Activity
T
The effects of Lithium on Beta-amyloid deposition and tau phosphorylation: A systematic review.
Kelei Xiao, Hisham Sayed, Jason Xing, Xin Yi Zhang, Jeffrey Ai, Joshua D Rosenblat

J Affect Disord· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.
Cristian-Daniel Llach, Sebastian Badulescu, Aniqa Tabassum, Hiya Shah, Hartej Gill, Joshua D Rosenblat

Mol Psychiatry· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.
Sami George Sabbah, Sophie Li, Sabrina Wong, Gia Han Le, Sebastian Badulescu, Joshua D Rosenblat

J Affect Disord· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.
Mary E Kittur, L Almendra Burgos M, Brett D M Jones, Daniel M Blumberger, Benoit H Mulsant, Joshua D Rosenblat

J Affect Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.
Mikkel Højlund, Helin Y Kafali, Begüm Kırmızı, Paolo Fusar-Poli, Christoph U Correll, Joshua D Rosenblat

Eur Neuropsychopharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.
Danica E Johnson, Shakila Meshkat, Erica S Kaczmarek, Jennifer S Rabin, Ryan M Brudner, Joshua D Rosenblat

Prog Neuropsychopharmacol Biol Psychiatry· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lithium therapy on blood glucose and insulin levels in individuals with bipolar disorder: A systematic review.
David Kanter-Eivin, Konstantin Blinkov, Sadie MacDonald, Jada Gibson, Sarah Pimenta, Joshua D Rosenblat

J Affect Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial.
Sebastian Badulescu, Hartej Gill, Hiya Shah, Ryan Brudner, Lee Phan, Joshua D Rosenblat

Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur.
Anees Bahji, Elisa Brietzke, Noah C A Cooke, Fiona Clement, Benicio N Frey, Joshua D Rosenblat

Can J Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorder.
Sipan Haikazian, Roger S McIntyre, Shakila Meshkat, Kevin Kratiuk, Cristian-Daniel Llach, Joshua D Rosenblat

Psychiatry Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.
Stanley Wong, Brett D M Jones, Mathura T Thiyagarajah, Sami G Sabbah, Chase Thompson, Joshua D Rosenblat

Ther Adv Psychopharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review of the Effects of N-Methyl-D-Aspartate Receptor Antagonists on Pancreatic Islets.
Sabrina Wong, Gia Han Le, John Uhlig, Ellen Yang, Christine E Dri, Joshua D Rosenblat

Neuroendocrinology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depression.
Ryan M Brudner, Erica Kaczmarek, Marc G Blainey, Christian Schulz-Quach, Shakila Meshkat, Joshua D Rosenblat

J Psychopharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Efficacy of Pharmacological Interventions in the Treatment of Major Depressive Disorder and Bipolar Depression With Mixed Features: A Systematic Review.
Naomi Xiao, Liyang Yin, Serene Lee, Kayla M Teopiz, Sabrina Wong, Joshua D Rosenblat

Bipolar Disord· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.
Margery J Q Chen, David Chen-Li, Noah Chisamore, M Ishrat Husain, Joshua D Di Vincenzo, Joshua D Rosenblat

Psychiatry Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between B cell activating factor (BAFF) and future depressive symptoms in hemodialysis patients.
Dong-Young Lee, Woojin Jang, Beom Kim, Jae-Hon Lee, Young Lee, Joshua D Rosenblat

Braz J Psychiatry· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sigma-1 receptor: a mechanistically-informed therapeutic target for antidepressants.
Naomi Xiao, Liyang Yin, Kayla M Teopiz, Angela T H Kwan, Gia Han Le, Joshua D Rosenblat

Expert Opin Ther Targets· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like Peptide-1 receptor agonists for the prevention and treatment of Parkinson's disease.
Serene Lee, Liyang Yin, Naomi Xiao, Taeho Greg Rhee, Heidi K Y Lo, Joshua D Rosenblat

CNS Spectr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Is Meant by the Term "Deprescribing," and Does It Belong in Our Lexicon?
Joseph F Goldberg, Holly A Swartz, Rajnish Mago, Roger S McIntyre, Gin S Malhi, Joshua D Rosenblat

J Clin Psychiatry· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder.
Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M Brudner, Fabiano A Gomes, Joshua D Rosenblat

Psychedelic Med (New Rochelle)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis